Although guidelines for population-based TB disease prevalence surveys exist, these cannot readily be used for measuring the prevalence of TB disease among health care workers, specific adaptations are needed. This guide is intended to provide that guidance for the specific setting of health care workers. This guide is designed to be used in combination with the WHO TB Prevalence Surveys: A Handbook.
This document lists the essential research questions that will provide a common framework for various scientific disciplines to work concurrently and collaboratively towards better TB control and elimination.
Dr. Kenneth Castro explains why it is important for people living with HIV to be tested for TB.
This brochure was developed for clinicians to use with patients while discussing the 12-dose regimen. The brochure contains information on latent TB infection, the 12-dose regimen, treatment schedules, and adverse events. There is space on this brochure to write in treatment schedules and clinic/office contact information.
The MDR-TB Planning Toolkit is designed to help assist countries develop or strengthen a multidrug-resistant tuberculosis (MDR-TB) component within their national TB strategy or plan. Eight tools contain worksheets to assist the user through key planning steps. The toolkit is intended for countries, technical partners, international organizations, and donors.
This course was designed to give hands-on practice in identifying when and how an Isoniazid Preventive Therapy (IPT) program can be used in the prevention of tuberculosis in people living with HIV. Depending on individual pace and previous knowledge, this course requires around 30 to 45 minutes to complete.
This is the seventeenth global report on tuberculosis (TB) published by WHO in a series that started in 1997. It provides a comprehensive and up-to-date assessment of the TB epidemic and progress in implementing and financing TB prevention, care and control at global, regional and country levels using data reported by 204 countries and territories that account for over 99% of the world’s TB cases.
This fact sheet provides information regarding TB/HIV coinfection worldwide. It also presents key activities being conducted by the WHO in response to TB/HIV coinfection.
Nine celebrities engaged in the fight against tuberculosis are launching a call to action to their friends and fans. They raise awareness through movies, music, television. They give patients a voice through their arts. They fight stigma and discrimination. They help with their time and commitment and need their efforts to be paired by other celebrities and their fans.
The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. For each of the three CDC-recommended LTBI regimens, there is a fact sheet in the series that can be personalized for individual patients. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.
